U.S. markets open in 1 hour 8 minutes
  • S&P Futures

    4,562.50
    -2.75 (-0.06%)
     
  • Dow Futures

    35,662.00
    +18.00 (+0.05%)
     
  • Nasdaq Futures

    15,529.00
    -16.00 (-0.10%)
     
  • Russell 2000 Futures

    2,283.40
    -10.50 (-0.46%)
     
  • Crude Oil

    83.78
    -0.87 (-1.03%)
     
  • Gold

    1,795.60
    +2.20 (+0.12%)
     
  • Silver

    24.15
    +0.06 (+0.26%)
     
  • EUR/USD

    1.1621
    +0.0019 (+0.16%)
     
  • 10-Yr Bond

    1.6190
    0.0000 (0.00%)
     
  • Vix

    16.15
    +0.91 (+5.97%)
     
  • GBP/USD

    1.3748
    -0.0016 (-0.11%)
     
  • USD/JPY

    113.6760
    -0.4530 (-0.40%)
     
  • BTC-USD

    58,824.34
    -3,792.77 (-6.06%)
     
  • CMC Crypto 200

    1,412.97
    -92.18 (-6.12%)
     
  • FTSE 100

    7,270.44
    -7.18 (-0.10%)
     
  • Nikkei 225

    29,098.24
    -7.77 (-0.03%)
     

Walgreens Increases Starting Wage for Hourly Team Members

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Pay increase recognizes the critical role of team members in serving customers, patients and communities

DEERFIELD, Ill., August 31, 2021--(BUSINESS WIRE)--Walgreens is further investing in its hourly team members who provide trusted care and services in communities across the U.S. Walgreens will increase the starting hourly wage for all team members to $15.00 an hour, taking effect in phases beginning in October of this year and are expected to be fully implemented by November 1, 2022.

"I am extremely proud and grateful of the work our team members are doing across our 9,000 Walgreens locations serving our customers, patients and communities each and every day," said Roz Brewer, CEO, Walgreens Boots Alliance. "Investing in and rewarding our team members is not only the right thing to do, it’s highly important to retaining and attracting a talented workforce, and to continuing to serve our critical role in community health care."

Since the beginning of the pandemic, Walgreens has made additional investments in support of its team members, including bonus payments and a significant hiring initiative, through which the company added 25,000 full-time and part-time pharmacy team members. Walgreens has also accelerated implementation of remote and digitalized pharmacy resources to enable pharmacists to spend more time with patients, and to allow all store team members to deliver the best service and care to customers and patients.

Total investment to support the starting wage increase is anticipated to be approximately $450 million over the next three years, with one-third of the amount invested in Fiscal Year 2022. The company anticipates that it will partially absorb the investment through the normal course of business.

Cautionary Note Regarding Forward-Looking Statements: All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These include, without limitation, statements regarding estimates of and goals for future operating, financial and tax performance and results, the expected execution and effect of our business strategies, the potential impacts on our business of the spread and effects of the COVID-19 pandemic, estimates of costs and potential financial impacts related to wage increases and our cost-savings and growth initiatives and their expected impacts. Words such as "expect," "likely," "outlook," "forecast," "preliminary," "pilot," "project," "intend," "plan," "goal," "target," "aim," "continue," "believe," "seek," "anticipate," "upcoming," "may," "possible," and variations of such words and similar expressions are intended to identify such forward-looking statements.

These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated. These risks, assumptions and uncertainties include those described in Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended August 31, 2020 and in other documents that we file or furnish with the Securities and Exchange Commission. If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. All forward-looking statements we make or that are made on our behalf are qualified by these cautionary statements. Accordingly, you should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

About Walgreens

Walgreens (www.walgreens.com) is included in the United States segment of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail pharmacy. As America’s most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and well-being of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210831005614/en/

Contacts

Media Relations
USA / Morry Smulevitz, +1 847 315 0517
USA/ Fraser Engerman, +1 414 308 8321
International, +44 (0)20 7980 8585

Investor Relations
Gerald Gradwell and Jay Spitzer, +1 847 315 2922